BioMed Research International

BioMed Research International / 2012 / Article

Research Article | Open Access

Volume 2012 |Article ID 867023 |

Hui-Fang Liu, Hui-Jie Zhang, Qi-Xian Hu, Xiao-Yan Liu, Zhi-Quan Wang, Jia-Yan Fan, Ming Zhan, Feng-Ling Chen, "Altered Polarization, Morphology, and Impaired Innate Immunity Germane to Resident Peritoneal Macrophages in Mice with Long-Term Type 2 Diabetes", BioMed Research International, vol. 2012, Article ID 867023, 9 pages, 2012.

Altered Polarization, Morphology, and Impaired Innate Immunity Germane to Resident Peritoneal Macrophages in Mice with Long-Term Type 2 Diabetes

Academic Editor: Soldano Ferrone
Received17 Mar 2012
Revised13 Jun 2012
Accepted29 Jun 2012
Published03 Oct 2012


Type 2 diabetes (T2D) is associated with perturbed innate immunity. Macrophages, bridging innate immunity and metabolic disturbances, play important roles in controlling immune homeostasis. However, the effect of long-term diabetic milieu (DM) on the functions and phenotypes of macrophages is still not clear. In this study, we used resident peritoneal macrophages (RPMs) from 5-month-old db/db mice to investigate the changes of macrophages. It was found that RPMs in db/db mice significantly reduced phagocytosis and adhesion capacity. After standardization with body weight, the number of F4/80+ RPMs markedly reduced in db/db mice, and, furthermore, the macrophages skewed to M2-polarizated macrophages. The results of morphology found that the RPMs shape of db/db mice was nearly round, but the RPMs shape of control mice was spindle-shaped and irregular. In this study, we found the cell numbers, morphology, and innate immunity functions of RPMs in 5-month-old type 2 diabetic mice (db/db mice) obtained by abdominal cavity lavage were significantly altered. Importantly, we also found the remarkably increased M2-RPMs in diabetic mice for the first time.

1. Introduction

Type 2 diabetes (T2D) is characterized by hyperglycemia and dyslipidemia resulting from a combination of insulin resistance in the skeletal muscle, liver, and adipose tissues, and impaired insulin secretion from the pancreatic islets, which is putatively due to impaired immune response [1]. Patients with T2D exhibit increased susceptibility to infection, impaired wound healing, and other inflammatory or degenerative manifestations [2]. It is the macrophage system dysfunction that leads to the major alterations among these innate immune abnormalities [3, 4]. Macrophage system including circulating monocytes, tissue macrophages, and dendritic cells is characterized by a high level of plasticity and widespread tissue distribution. It was observed that phagocytes in type 2 diabetic patients were in a heightened state of oxidative stress accompanied by impaired bactericidal activity and chemotaxis [57]. Furthermore, the receptor functions, levels of cytokines expression, and release of the macrophages derived from the peripheral blood of T2D patients all changed dramatically [810].

Monocytes derived from bone marrow remain in the blood circulation system for 1-2 days before they migrate into the peripheral tissues, where they differentiate into fully mature resident macrophages. In innate immunity, resident macrophages provide immediate defense against foreign pathogens and assist leukocyte infiltration [11]. Resident macrophage population is composed of various cells, including macrophages in the peritoneal cavity, which is thought fully developed and adaptable to their local microenvironment with a wide diversity in terms of their function and phenotype [12, 13]. The evidence that macrophages could display different activation states with distinct properties provided us with clues to understand diverse functions of macrophages [14]. Two polarized states in activated macrophages have been defined, the pro-inflammatory, classically activated state M1 induced by type I cytokines (e.g., TNF) or bacterial products (e.g., LPS) and the anti-inflammatory, alternatively activated phenotype M2 induced by IL-4, IL-10, or glucocorticoid hormones [15, 16]. These different phenotypes of macrophages were expressed in such a manner that macrophages display a balanced, integrated pattern of functions [14, 17].

Most of the current understanding of macrophage biology came from analyses of cells drawn from the mouse peritoneal cavity, which became widely used as a macrophage source as early as the 1960s [18]. A recent study reported marked difference between resident and induced macrophages, such as the efficacy of killing pathogenic microorganisms and antigen presentation [19]. Furthermore, studies about alteration of macrophage characteristics in diabetes were performed in streptozotocin- (STZ-) induced type 1 diabetic mouse model, which was accompanied by immunological dysfunction [20]. It is hard to determine whether the dysfunctions of macrophages in these diabetes hosts were solely caused by diabetes itself or just by the host immunological dysfunction. To the best of our knowledge, little is known about the polarized states of RPMs.

To provide evidence showing the effects of DM with long duration on cell numbers, morphology, and innate immunity functions of macrophages in vivo, we used resident peritoneal macrophages (RPMs) from 5-month-old db/db mice obtained by abdominal cavity lavage to study the changes. The result may help us to understand the susceptibility of diabetic patients to infectious diseases and other complications in the late stage of diabetes.

2. Materials and Methods

2.1. Reagents

Ethylenediaminetetraacetic acid (EDTA), N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP), paraformaldehyde, modified Wright-Giemsa stain solution, and fluorescent red, carboxylate-modified polystyrenelatex beads were purchased from Sigma-Aldrich (St. Louis, MO, USA). RPMI-1640, fetal bovine serum (FBS), penicillin/streptomycin, and phosphate buffered saline (PBS) were obtained from Gibco BRL (Grant Island, NY, USA). Bovine serum albumin (BSA) was ordered in BD Pharmingen (San Diego, CA, USA). Beyotime Institute of Biotechnology provided crystal violet staining solution (Shanghai, China).

2.2. Animals

Eight-to-twelve-week-old male db/db (C57BL/6J- L e p r d b / L e p r d b ) mice and littermate controls (C57BL/6J background) were fed chow (LabDiet 5001) and bought from the Model Animal Research Center of Nanjing University (Nanjing, China). All mice were kept in a specific pathogen-free facility and given free access to food and water. The experiment was performed strictly in accordance with the institutional guidelines for the care and use of laboratory animals of Shanghai Jiao Tong University.

2.3. Isolation and Culture of Mouse RPMs

Mouse RPMs were obtained by the modified method of Cohn and Benson [21]. Approximately 6 mL cold serum-free RPMI-1640 medium was injected intraperitoneally after mice were killed under ether anesthesia. After a gentle massage, peritoneal fluid containing cells was harvested and centrifuged at 700 g for 5 min at 4°C. The pellet was resuspended with 5 mL of RPMI-1640 containing 10% FCS, 100 units/mL penicillin, and 100 μg/mL streptomycin and cultured at 37°C in a 35 mm dish (Corning, NY, USA) for one hour, and only attached macrophages were used for the following experiments. Adherent cells were collected with 5 mm EDTA (Sigma-Aldrich) in ice-cold PBS (Gibco BRL). The cell viability was more than 90%, and more than 90% of adherent cells were F4/ 8 0 + macrophages, as reported previously [22, 23].

2.4. Morphology Observation

RPMs from db/db or control mice (1 × 105) were cultured in 24-well plates containing 12 mm sterilized glass slides per well for 2 h. For microscopic studies, the adherent cells were stained by modified Wright-Giemsa stain (Sigma-Aldrich) according to manufacturer’s protocol. The glass slides were rinsed briefly in running deionized water (PH7.2) and dried in air thoroughly before capturing images by a microscope (Olympus BX51, Olympus Optical, Tokyo, Japan).

2.5. Immunofluorescence Staining and Laser Confocal Scanning Microscopy

RPMs from db/db or C57BL/6J mice were collected then cultured on 24-well plates containing 12 mm glass slides at a concentration of 2 × 105 macrophages per well for 2 h. The adherent macrophages were fixed in 4% paraformaldehyde (Sigma-Aldrich) for 20 min then incubated in PBS with 0.5% BSA at 4°C for 30 min in order to avoid nonspecific binding to FcR. Primary antibodies against F4/80 (EMR1: R&D Systems, USA) and Cy3-labeled second antibodies (Beyotime Institute of Biotechnology, Shanghai, China) were sequentially incubated with macrophages for overnight at 4°C and 2 h at room temperature, respectively. After DAPI (Invitrogen, San Diego, CA, USA) staining, cells were analyzed under laser confocal scanning microscopy (LSM510, Zeiss, Germany).

2.6. Immunofluorescence Staining and Flow Cytometry

At least 5 × 105 RPMs were incubated with 2.4 G2 (BD Biosciences) for 10 min at room temperature then with primary antibodies or the matching control isotypes for 30 min at 4°C. Thereafter, the cells were rinsed twice and resuspended in Pharmingen stain buffer (BD Biosciences) for assay by FACScalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ). The data were analyzed with Cell Quest software (Becton Dickinson, Mountain, CA, USA). For three-color staining, RPMs were stained with phycoerythrin-Cy5 (PE-Cy5-) labeled anti-F4/80 monoclonal antibodies (mAbs) (eBiosciences, San Diego, CA, USA), phycoerythrin (PE-) labeled anti-CD40 (eBiosciences) mAbs, or fluorescein isothiocyanate (FITC-) labeled anti-CD206 mAbs (BioLegend, San Diego, CA, USA) for 30 min at 4°C. M1 and M2 macrophages were identified as F4/ 8 0 + / C D 4 0 + / C D 2 0 6 and F4/ 8 0 + / C D 4 0 / C D 2 0 6 + cells, respectively.

2.7. Phagocytosis Assay

RPMs (4 × 105) were seeded in a 6-well plate then incubated with fluorescent red, carboxylate-modified polystyrenelatex beads (8 × 106 beads) for 2 h at 37°C, while the control were incubated at 4°C. The cells were washed with PBS before harvest and then resuspended in PBS containing 5% BSA. The phagocytic activity of RPMs was determined by measuring phagocytic rate and mean fluorescence intensity (MFI) with FACScalibur flow cytometer (Becton and Dickinson).

2.8. Adherence Assay

The adherence capacity of RPMs was evaluated by the adherence index (AI), capacity of adherent to plastic surfaces [24]. Briefly, 500 μL RPMI-1640 complete medium containing 7.5 × 105 RPMs was placed in each Eppendorf tube, incubated at 37°C with 5% CO2 in a shaking bath for 10, 30, or 60 min, respectively. AI was calculated according to the equation: AI = 100 − (number of macrophages ( m L s u p e r n a t a n t ) 1 /number of macrophages ( m L o r i g i n a l s a m p l e ) 1 )100.

2.9. Chemotaxis Assay

Chemotaxis experiment was carried out in 6.5 mm polycarbonate membrane inserts (Costar, Cambridge, MA, USA) with a 5 μm pore size. Briefly, 100 μL RPMs suspension (1.3 × 105/well) was deposited in the insert and 600 μL RPMI-1640 containing FMLP (Sigma-Aldrich) (0.1 mmol) was added into the lower compartment to induce chemotaxis for 2 h [25]. After the nonmigrated cells were removed from the polycarbonate membrane upper side, the migrated cells which were on the lower side were fixed and stained by crystal violet staining solution (Beyotime Institute of Biotechnology). The chemotactic index (CI) is presented as the total number of migrated cells of 16 random selected microscopic fields (at ×400 magnification).

2.10. Statistical Analysis

Data were expressed as means ± standard deviation (SD). Student’s unpaired t-test for comparison of means was used to compare means of each group. Differences were considered statistically significant at P < 0.05.

3. Results

3.1. Significantly Decreased Cell Numbers and Altered Cellular Morphology of F4/ 8 0 + RPMs in 5-Month-Old db/db Mice

To determine the long effect of T2D on cell numbers and cellular morphology of RPMs in db/db mice, we identified resident macrophages by detecting the surface antigens F4/80 firstly. The purity of mouse F4/ 8 0 + RPMs was routinely determined by FCM before each assay, which was more than 90% (Figure 1(a)). As shown in Figure 1(b), the total cell numbers of F4/ 8 0 + RPMs in each db/db mouse were far greater than that of control (P < 0.01, n = 6). However, after the data were standardized with body weight, the result of RPM numbers reversed (Figure 1(c)). The morphology of RPMs was determined by Wright-Giemsa stain and a two-photon laser scanning. As shown in Figures 1(e) and 1(g), freshly isolated F4/ 8 0 + RPMs from db/db mice were nearly round shape, while that from control mice displayed spindle-shaped or irregular morphology (Figures 1(d) and 1(f)). Thus, a significant alteration of cell numbers and morphology of F4/ 8 0 + RPMs occurred in the mice with a long duration of DM.

3.2. Nonspecific Phagocytosis Deficiency of F4/ 8 0 + RPMs from 5-Month-Old db/db Mice

Phagocytosis represents an early and crucial event in triggering host defenses against invading pathogens. The nonspecific phagocytic capacity of F4/ 8 0 + RPMs against fluorescence-modified polystyrenelatex beads was assessed by using FCM and shown in Figure 2. As compared with mice in the control group (Figure 2(b)), cell-related fluorescence intensity corresponding to the peak of the histograms moved to the left in db/db mice, which indicated that fewer fluorescent beads were ingested by macrophages (Figure 2(d)). Both the phagocytic rate (Figure 2(e), P < 0.001, n = 4) and MFI of RPMs from db/db mice were much lower than those of control group (Figure 2(f), P < 0.001, n = 4).

3.3. Impaired Adhesion Vitality and Chemotaxis Capacity of F4/ 8 0 + RPMs in 5-Month-Old db/db Mice

To further determine other functional changes like adhesion and chemotaxis in macrophage from mice with a long duration of diabetes, we investigated the chemotaxis and adhering capacity of RPMs. It was showed in Figures 3(b) and 3(d) that RPMs from control or db/db mice migrated to the lower side of the filter after exposure to 0.1 mmol FMLP for 2 h by crystal violet staining. The values of CI of RPMs in diabetic mice were lower than those of control without significant difference (Figure 3(e), P > 0.05, n = 4). The adhering capacity of RPMs was assayed at selected time points (10 min, 30 min, and 60 min), respectively, after macrophages were placed in each eppendorf tube for a shaking bath as described in Section 2. As shown in Figure 3(f), the values of AI of RPMs from db/db mice were all significantly lower than those of the controls (P < 0.01, n = 4).

3.4. Phenotype Changes of F4/ 8 0 + RPMs in 5-Month-Old db/db Mice

The expression of CD40 on macrophages after activation is critically related to the efficient promotion of adaptive immunity by macrophages. CD206 expression is an important marker for IL-4-induced M2 macrophages [26]. Thus, we detected CD40 and CD206 expressions on RPMs from db/db or control mice by FCM to study the polarized state as described in Section 2. As shown in Figure 4(c), the percentage of M2 (F4/ 8 0 + / C D 4 0 / C D 2 0 6 + ) macrophages (P < 0.01, n = 4) of RPMs in db/db mice was significantly higher than that of control mice, and the percentage of M1 (F4/ 8 0 + /CD 4 0 + / C D 2 0 6 ) macrophages of RPMs in db/db mice reduced accordingly.

4. Discussion

In the present study, we explored the pathogenesis of diabetes mellitus (DM) with the classical type 2 diabetic mouse model. It was demonstrated in our study that long duration of T2D significantly altered cell numbers, morphology, phenotypes, and functions of resident peritoneal macrophages.

The severe complications of diabetes including impaired wound healing and accelerated atherosclerosis may increase patient’s susceptibility to infection and make the infected tissue difficult to be repaired [27]. It was well accepted that the dysfunction of the macrophage system may contribute to these complications. Macrophages play important roles in innate immunity, which help host to defense microbial invaders through producing various cytokines and phagocytosis.

In our study, it was found that the cell numbers of F4/ 8 0 + RPMs in each 5-month-old db/db mouse increased obviously, which was contradicted with a previous study performed in STZ-induced type 1 diabetic (T1D) mice without standardization of mouse’s body weight. Ma et al. presumed that the reduction of F4/ 8 0 + RPMs in T1D mice was probably related with shortened life span of macrophages and/or the blocking differentiation of macrophages from monocytes or bone marrow cells (BMCs) [20]. Another preliminary study in vitro also showed that only a low level of macrophages was generated in NOD BMCs after being stimulated with GM-CSF [28]. Interestingly, when the number of F4/ 8 0 + RPMs with mouse’s body weight was standardized, the result was reversed. As db/db mice are larger while STZ-induced T1D mice are much smaller than control, the number of F4/ 8 0 + RPMs from each mouse may be positively correlated with animal body weight. Nevertheless, as it is well accepted that diabetes and obesity lead to a chronic low-grade inflammation, diabetes-associated inflammation is correlated with elevated macrophage cell numbers. Previous report about the percentage of bone marrow-derived cells expressing the macrophage marker F4/80 (F4/ 8 0 + ) in perigonadal, perirenal, mesenteric, and subcutaneous adipose tissue by immunohistochemical analysis revealed that it was significantly and positively correlated with both adipocyte size and body mass [29]. However, the specific mechanism of different macrophage distribution between adipose tissue and abdominal cavity is still unclear. In the present study, we demonstrated for the first time that the number of RPMs from each mouse was positively correlated with animal body weight.

Furthermore, we were the first to find that the RPMs from db/db mice were nearly round in shape as compared with those of control mice with spindle-shaped or irregular morphology. It is not surprising that macrophage heterogeneity presents in different organs or tissues, as well as even in a single organ [30]. Recent studies showed that macrophage phenotypic and functional heterogeneity might be related to a wide diversity of factors, including different precursor cells, different differentiation stages, different microenvironments, or even different stimulatory factors [31]. The response of F4/ 8 0 + peritoneal macrophages from STZ-induced diabetic mouse at 4 months and control mouse to IFN-γ and LPS was also different, which demonstrated that macrophages from diabetic mice produced much less TNF-α and IL-6 than those of control mice through AKT-mTOR and ERK pathways [32]. Hence, this morphologic heterogeneity in RPMs between db/db and control mice may hint at the discrepancy of cell physiological functions; the potential mechanism might be related with the alteration of microenvironments, levels of blood glucose, dyslipidemia, and advanced glycation end products.

Macrophages can engulf foreign pathogens, microorganisms and dead cells, which are essential steps of cellular immunity and a part of innate immunity. It was found that phagocytic capacity of F4/ 8 0 + RPMs from 5-month-old diabetic mice was lower than that of control with method of detecting the amount of phagocytosis fluorescence-modified polystyrenelatex beads by FCM. The decreased nonspecific phagocytosis ability of macrophages in diabetic hosts was consistent with several reports about the diabetic host with increased susceptibility to microorganism infection [33, 34]. Furthermore, remarkably impaired adhesion ability of RPMs was also observed in db/db mice. Attenuated adhesion ability in RPMs from db/db mice may also be responsible for the dysfunction immunity though this test could not completely mimic the process of macrophages adhesion to endothelial cells in vivo as a first step in the inflammation reaction. However, the mechanismsof macrophages from diabetic hosts with inhibited adhesion capacity need further study. Lastly, the chemotaxis vitality of RPMs from db/db mice was also found to be impaired although no significant difference between the two groups was identified. Because the strong relationship between the adipose tissue macrophage content and indicators of adiposity in diabetic mouse provides a mechanism for the increased adipose tissue production of proinflammatory molecules and acute phase proteins, such as TNF-α, IL-6, and MCP-1 [35]. And increased adipocyte volume and number in diabetic mice are also positively correlated with leptin production, while negatively correlated with production of adiponectin [36, 37]. As it is well accepted that huge array of environmental factors (including cytokines, chemokines, pattern recognition receptors, and hormones) differentially regulates macrophage response [38], in our study the decreased nonspecific phagocytosis, adhesion, and chemotaxis ability of RPMs in diabetic hosts may be related to the abnormal microenvironment in db/db mouse. On the other hand, these findings support the possibility that interrupted wound healing, and complications associated with inflammatory in DM patients, at least in part, is due to the dysfunction of macrophages in phagocytosis, adhesion, and chemotaxis.

During enhanced recruitment in response to disease states, inflammatory monocytes are recruited in response to cytokine cues and undergo differentiation into two broad but distinct subsets of macrophages that are categorized as either classically activated (M1) or alternatively activated (M2). The expression of costimulatory molecules such as CD80, CD86, CD40, and CD54 on macrophages after activation is critically related to the efficient promotion of adaptive immunity by macrophages [39]. CD206 expression is a specific marker for IL-4-induced M2 macrophages, which was used by C. Sun as the M2 marker in a flow cytometry analysis [32]. Hence, we selected the markers CD40 and CD206 as M1 and M2 macrophages, respectively, for our study. Our result showed the proportion of anti-inflammatory M2-type RPMs was doubled in db/db group compared with the control group. This result was similar with another study in vitro, which showed that markers on peritoneal macrophages isolated from STZ-induced diabetes mice at 4 months after activation were significantly lower compared to control mice as determined by the percentage of positive cells and MFI of CD86 and CD54 expression; whereas arginase activity, another important marker for alternatively activated macrophages, was significantly higher in peritoneal macrophages isolated from STZ-induced diabetes mice than those of control mice when stimulated with IL-4 [32].

Macrophages not only get involved in the etiology of DM and its chronic complications but also defense pathogens, and their proper activated state determines the result of the host response to pathogen aggression. The M1 program of macrophages is usually associated with protection during acute infectious diseases and thought to damage neighboring tissues; M2 macrophages having immunosuppressive and tissue-repairing functions play critical roles in the resolution of harmful inflammation by producing anti-inflammatory mediators [40, 41]. Therefore, an increased proportion of M2 RPMs in the db/db mice may be related with the chronic low-grade inflammation in abdominal cavity. However, db/db mouse is a genetically deficient mouse, and IL-4 signaling in db/db macrophages was alleviated compared with db / + or macrophages from control mice, which indicated that the impaired IL-4 pathway in macrophages from the db/db mouse model of T2D may induce a state of IL-4 resistance and finally disrupt IL-4-dependent M2 phenotype macrophage yield [42]. This seemingly contradictory result needs further study to explain.

In summary, our study clearly showed that an increased percentage of M2 type RPMs accompanied with remarkable innate immunity dysfunction occurred in type 2 diabetic mice in vivo with a long duration. This study may help us to understand the susceptibility of diabetic patients to infectious diseases and other complications in the patients of diabetes. However, further investigation is needed to clarify the mechanisms involved and possible methods to ameliorate this alteration.


AI:Adherence index
CI:Chemotactic index
DM:Diabetic milieu
FMLP: N-formyl-L-methionyl-L-leucyl-L-phenylalanine
FITC:Fluorescein isothiocyanate
FCM:Flow cytometry
MFI:Median fluorescenceintensity
PMNs:Polymorphonuclear neutrophils
RPMs:Resident peritoneal macrophages
T2D: Type 2 diabetes
T1D: Type 1 diabetes.


This study has been funded by Grants to F.-L. Chen from the National Science Foundation of China (30870954), the Foundation for Science and Technology, Shanghai Jiao tong University School of Medicine (YZ1054), the talent project funded by Shanghai Jiao tong University School of Medicine (09XBR01), and the fund for Science and Technology from Third People’s Hospital affiliated to Shanghai Jiao tong University Medicine of School (syz2010-02).


  1. J. M. Fernández-Real and J. C. Pickup, “Innate immunity, insulin resistance and type 2 diabetes,” Diabetologia, vol. 55, no. 2, pp. 273–278, 2012. View at: Publisher Site | Google Scholar
  2. G. H. Tesch, “Role of macrophages in complications of Type 2 diabetes,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 10, pp. 1016–1019, 2007. View at: Publisher Site | Google Scholar
  3. C. N. Lumeng, J. B. Delproposto, D. J. Westcott, and A. R. Saltiel, “Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes,” Diabetes, vol. 57, no. 12, pp. 3239–3246, 2008. View at: Publisher Site | Google Scholar
  4. B. N. Lambrecht, “Alveolar macrophage in the driver's seat,” Immunity, vol. 24, no. 4, pp. 366–368, 2006. View at: Publisher Site | Google Scholar
  5. F. Y. Chang and M. F. Shaio, “Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 29, no. 2, pp. 121–127, 1995. View at: Publisher Site | Google Scholar
  6. R. Shurtz-Swirski, S. Sela, A. T. Herskovits et al., “Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients,” Diabetes Care, vol. 24, no. 1, pp. 104–110, 2001. View at: Google Scholar
  7. A. Wykretowicz, B. Wierusz-Wysocka, J. Wysocki, A. Szczepanik, and H. Wysocki, “Impairment of the oxygen-dependent microbicidal mechanisms of polymorphonuclear neutrophils in patients with type 2 diabetes is not associated with increased susceptibility to infection,” Diabetes Research and Clinical Practice, vol. 19, no. 3, pp. 195–201, 1993. View at: Publisher Site | Google Scholar
  8. C. Romano-Carratelli, M. Galdiero, C. Bentivoglio, I. Nuzzo, D. Cozzolino, and R. Torella, “HLA class II antigens and interleukin-1 in patients affected by type-II diabetes mellitus and hyperlipemia,” Journal of Medicine, vol. 24, no. 1, pp. 28–34, 1993. View at: Google Scholar
  9. Y. Ohno, N. Aoki, and A. Nishimura, “In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 4, pp. 1072–1077, 1993. View at: Publisher Site | Google Scholar
  10. B. Kulseng, G. Skjåk-BræK, I. Følling, and T. Espevik, “TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide,” Scandinavian Journal of Immunology, vol. 43, no. 3, pp. 335–340, 1996. View at: Google Scholar
  11. L. Martinez-Pomares, D. M. Reid, G. D. Brown et al., “Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies,” Journal of Leukocyte Biology, vol. 73, no. 5, pp. 604–613, 2003. View at: Publisher Site | Google Scholar
  12. J. E. Volanakis, “The role of complement in innate and adaptive immunity,” Current Topics in Microbiology and Immunology, vol. 266, pp. 41–56, 2002. View at: Google Scholar
  13. S. Gordon, “Alternative activation of macrophages,” Nature Reviews Immunology, vol. 3, no. 1, pp. 23–35, 2003. View at: Publisher Site | Google Scholar
  14. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati, “The chemokine system in diverse forms of macrophage activation and polarization,” Trends in Immunology, vol. 25, no. 12, pp. 677–686, 2004. View at: Publisher Site | Google Scholar
  15. D. M. Mosser, “The many faces of macrophage activation,” Journal of Leukocyte Biology, vol. 73, no. 2, pp. 209–212, 2003. View at: Publisher Site | Google Scholar
  16. T. M. B. Rezende, D. L. Vargas, F. P. Cardoso, A. P. R. Sobrinho, and L. Q. Vieira, “Effect of mineral trioxide aggregate on cytokine production by peritoneal macrophages,” International Endodontic Journal, vol. 38, no. 12, pp. 896–903, 2005. View at: Publisher Site | Google Scholar
  17. A. Mantovani, A. Sica, and M. Locati, “Macrophage polarization comes of age,” Immunity, vol. 23, no. 4, pp. 344–346, 2005. View at: Publisher Site | Google Scholar
  18. R. M. Steinman and C. L. Moberg, “Zanvil Alexander Cohn 1926–1993,” Journal of Experimental Medicine, vol. 179, no. 1, pp. 1–30, 1994. View at: Google Scholar
  19. L. R. Turchyn, T. J. Baginski, R. R. Renkiewicz, C. A. Lesch, and J. L. Mobley, “Phenotypic and functional analysis of murine resident and induced peritoneal macrophages,” Comparative Medicine, vol. 57, no. 6, pp. 574–580, 2007. View at: Google Scholar
  20. H. Ma, G. Liu, W. Ding, Y. Wu, L. Cai, and Y. Zhao, “Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term,” Journal of Molecular Medicine, vol. 86, no. 4, pp. 391–400, 2008. View at: Publisher Site | Google Scholar
  21. Z. A. Cohn and B. Benson, “The differentiation of mononuclear phagocytes. morphology, cytochemistry, and biochemistry,” The Journal of Experimental Medicine, vol. 121, pp. 153–170, 1965. View at: Google Scholar
  22. W. Z. Ho, J. P. Lai, X. H. Zhu, M. Uvaydova, and S. D. Douglas, “Human monocytes and macrophages express substance P and neurokinin-1 receptor,” Journal of Immunology, vol. 159, no. 11, pp. 5654–5660, 1997. View at: Google Scholar
  23. E. E. Bou Ghosn, A. A. Cassado, G. R. Govoni et al., “Two physically, functionally, and developmentally distinct peritoneal macrophage subsets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 6, pp. 2568–2573, 2010. View at: Publisher Site | Google Scholar
  24. K. Imaizumi, T. Kawabe, S. Ichiyama et al., “Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction,” The American Journal of Physiology, vol. 277, no. 1, part 1, pp. L49–L57, 1999. View at: Google Scholar
  25. C. Yang, J. Y. Zhou, H. J. Zhong et al., “Exogenous norepinephrine correlates with macrophage endoplasmic reticulum stress response in association with XBP-1,” Journal of Surgical Research, vol. 168, no. 2, pp. 262–271, 2011. View at: Publisher Site | Google Scholar
  26. S. Fujisaka, I. Usui, A. Bukhari et al., “Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice,” Diabetes, vol. 58, no. 11, pp. 2574–2582, 2009. View at: Publisher Site | Google Scholar
  27. B. R. Shah and J. E. Hux, “Quantifying the risk of infectious diseases for people with diabetes,” Diabetes Care, vol. 26, no. 2, pp. 510–513, 2003. View at: Publisher Site | Google Scholar
  28. T. Nikolic, M. Bunk, H. A. Drexhage, and P. J. M. Leenen, “Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro,” Journal of Immunology, vol. 173, no. 7, pp. 4342–4351, 2004. View at: Google Scholar
  29. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at: Publisher Site | Google Scholar
  30. L. Monney, C. A. Sabatos, J. L. Gaglia et al., “Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease,” Nature, vol. 415, no. 6871, pp. 536–541, 2002. View at: Publisher Site | Google Scholar
  31. D. Chakraborty, S. Banerjee, A. Sen, K. K. Banerjee, P. Das, and S. Roy, “Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts,” Journal of Immunology, vol. 175, no. 5, pp. 3214–3224, 2005. View at: Google Scholar
  32. C. Sun, L. Sun, H. Ma et al., “The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term,” Journal of Cellular Physiology, vol. 227, no. 4, pp. 1670–1679, 2012. View at: Publisher Site | Google Scholar
  33. M. Ferracini, J. O. Martins, M. R. M. Campos, D. B. C. Anger, and S. Jancar, “Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the Fc γ R signaling cascade,” Molecular Immunology, vol. 47, no. 11-12, pp. 1974–1980, 2010. View at: Publisher Site | Google Scholar
  34. B. F. Liu, S. Miyata, H. Kojima et al., “Low phagocytic activity of resident peritoneal macrophages in diabetic mice: Relevance to the formation of advanced glycation end products,” Diabetes, vol. 48, no. 10, pp. 2074–2082, 1999. View at: Publisher Site | Google Scholar
  35. P. Sartipy and D. J. Loskutoff, “Monocyte chemoattractant protein 1 in obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7265–7270, 2003. View at: Publisher Site | Google Scholar
  36. Y. Zhang, K. Y. Guo, P. A. Diaz, M. Heo, and R. L. Leibel, “Determinants of leptin gene expression in fat depots of lean mice,” The American Journal of Physiology, vol. 282, no. 1, pp. R226–R234, 2002. View at: Google Scholar
  37. E. Tomas, T. S. Tsao, A. K. Saha et al., “Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16309–16313, 2002. View at: Publisher Site | Google Scholar
  38. R. D. Stout and J. Suttles, “Functional plasticity of macrophages: reversible adaptation to changing microenvironments,” Journal of Leukocyte Biology, vol. 76, no. 3, pp. 509–513, 2004. View at: Publisher Site | Google Scholar
  39. J. K. Lee, M. H. Ryu, and J. A. Byun, “Immunotoxic effect of β-chlorolactic acid on murine splenocyte and peritoneal macrophage function in vitro,” Toxicology, vol. 210, no. 2-3, pp. 175–187, 2005. View at: Publisher Site | Google Scholar
  40. M. Benoit, B. Desnues, and J. L. Mege, “Macrophage polarization in bacterial infections,” Journal of Immunology, vol. 181, no. 6, pp. 3733–3739, 2008. View at: Google Scholar
  41. P. J. Murray and T. A. Wynn, “Protective and pathogenic functions of macrophage subsets,” Nature Reviews Immunology, vol. 11, no. 11, pp. 723–737, 2011. View at: Publisher Site | Google Scholar
  42. J. C. O'Connor, C. L. Sherry, C. B. Guest, and G. G. Freund, “Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3,” Journal of Immunology, vol. 178, no. 11, pp. 6886–6893, 2007. View at: Google Scholar

Copyright © 2012 Hui-Fang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles